SCPX (Scorpius Holdings, Inc.) Utang jangka cendhak marang modal

The confirmed price history on the chart shows that the debt-to-equity ratio for Scorpius Holdings, Inc. (SCPX) is 0.08. The business relies on the operation of advanced bioreactors and the modernization of sterile filling systems. New production capacities and an expanding order book for biopharmaceutical development are driving the company's growth. Overall, Scorpius Holdings, Inc. (SCPX) is developing its contract manufacturing infrastructure, becoming a key operational link for developers of modern therapies.

This indicator is calculated as the ratio of liabilities with a maturity of up to one year to equity, measuring the balance sheet's dependence on short-term borrowing and the risk of cash flow gaps as borrowing costs rise. For Scorpius Holdings, Inc. (SCPX), stable cash flow from the Inertia CDMO segment should offset the pressure of short-term debt, which is reflected in the current ratio of short-term borrowed capital to equity.